Profile
Andrew Derodra served as the Chief Financial Officer & Executive Director at SkyePharma Plc and as the Director-Business Transformation at ABI SAB Group Holding Ltd. He also worked as the Vice President-Finance & Control at Tate & Lyle Plc.
From 2016 to 2018, he served as the Chief Financial Officer & Director at Vectura Group Ltd. Mr. Derodra completed his undergraduate degree at the University of Oxford.
Former positions of Andrew Derodra
| Companies | Position | End |
|---|---|---|
| VECTURA GROUP | Director of Finance/CFO | 2018-07-30 |
| SABMILLER PLC | Corporate Officer/Principal | - |
| TATE & LYLE PLC | Corporate Officer/Principal | - |
| SKYEPHARMA PLC | Director of Finance/CFO | - |
Training of Andrew Derodra
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
SkyePharma Plc
SkyePharma Plc Pharmaceuticals: OtherHealth Technology Manufactures and develops oral and inhalation pharmaceutical products | Health Technology |
ABI SAB Group Holding Ltd.
ABI SAB Group Holding Ltd. Beverages: AlcoholicConsumer Non-Durables Engages in manufacturing and distributing beers and beverages | Consumer Non-Durables |
Vectura Group Ltd.
Vectura Group Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures inhalation drugs and medical devices | Health Technology |
Tate & Lyle Plc
Tate & Lyle Plc Food: Specialty/CandyConsumer Non-Durables Manufactures sweeteners, industrial starches and ingredients | Consumer Non-Durables |
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Andrew Derodra
















